Press Releases

	09-17-2007		Review of projections for 2007
	08-30-2007		Erratum for the Summary Financial Data and Information for the Period from January 1st 2007 to June 30th 2007 of LAVIPHARM S.A.
	06-18-2007		Announcement
	06-15-2007		Announcement for the Schedule of Intended Corporate Actions
	05-30-2007		Increased Turnover and EBITDA for Lavipharm Group in Q1 2007
	05-16-2007		Lavipharm S.A. - Share Capital Increase
	03-05-2007		Lavipharm announces the approval to market its generic fentanyl in Greece
	11-30-2006		Lavipharm Group: 49.5% Increase of EBITDA for Q3 2006
	11-03-2006		1st Price in Entrepreneurial innovation
	08-30-2006		Lavipharm's imminent entry in the US market opens new horizons for the Group
	08-07-2006		FDA Approval to Lavipharm's Fentanyl Patch
	06-27-2006		Lavipharm's Trinipatch enters the Canadian market
	03-28-2006		Lavipharm: Financial Improvement, Decrease of Loans and Expenses in 2005
	02-21-2006		Exploration of New Activities and Co-operations in China
	02-02-2006		CASTALIA Welcomes Chinese New Year
	01-20-2006		LAVIPHARM'S Chinese Presence